Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC Working Group for PTH.

Clinica chimica acta; international journal of clinical chemistry·2016
Same author

Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2015
Same author

Validation of new cancer biomarkers: a position statement from the European group on tumor markers.

Clinical chemistry·2015
Same author

The harmonisation of growth hormone measurements: taking the next steps.

Clinica chimica acta; international journal of clinical chemistry·2014
Same author

External quality assessment of hormone determinations.

Best practice & research. Clinical endocrinology & metabolism·2013
Same author

Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review.

Clinical chemistry and laboratory medicine·2013

Related Experiment Video

Updated: May 5, 2026

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
09:08

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

Published on: September 12, 2016

7.7K

Common decision limits --The need for harmonised immunoassays.

Catharine M Sturgeon1

  • 1UK NEQAS [Edinburgh], Department of Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|December 3, 2013
PubMed
Summary

Clinical guidelines aim for optimal patient outcomes and resource use. Method-related differences in analyte measurements, like prostate-specific antigen, can lead to serious patient implications, necessitating standardization.

Keywords:
Clinical outcomeDecision limitsMethod-related differencesStandardisation

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.9K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K

Related Experiment Videos

Last Updated: May 5, 2026

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
09:08

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

Published on: September 12, 2016

7.7K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.9K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K

Area of Science:

  • Clinical Chemistry
  • Medical Diagnostics
  • Biochemical Analysis

Background:

  • Clinical guidelines are essential for standardizing patient care and resource allocation.
  • Decision limits in guidelines often rely on analyte levels in biological samples (serum, plasma, urine).
  • Discrepancies between different measurement methods can impact clinical decisions.

Purpose of the Study:

  • To highlight the importance of addressing method-related differences in clinical guideline implementation.
  • To emphasize the potential serious patient consequences arising from variations in analyte measurements.
  • To review causes of between-method differences and propose solutions.

Main Methods:

  • Review of existing evidence on method-related differences in analyte measurements.
  • Analysis of the impact of these differences on clinical decision-making.
  • Identification of major causes contributing to measurement variability.

Main Results:

  • Method-related differences in analyte measurements can significantly affect patient management.
  • Examples include prostate-specific antigen (PSA) testing, where variations can lead to missed or unnecessary biopsies.
  • Significant implications for patient care exist if common decision limits are implemented without considering method variability.

Conclusions:

  • Standardization of measurement methods is crucial for the reliable application of clinical guidelines.
  • Addressing between-method differences is necessary to ensure consistent and accurate patient diagnosis and treatment.
  • Further efforts are needed to minimize analytical variability and improve patient outcomes.